{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:06:10Z","timestamp":1785333970451,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,29]]},"DOI":"10.7759\/cureus.113592","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:24:12Z","timestamp":1785331452000},"source":"Crossref","is-referenced-by-count":0,"title":["Concurrent Kaposi Sarcoma and B-cell Lymphoma in an HIV-Negative Patient: A Case Report"],"prefix":"10.7759","author":[{"given":"Marwa","family":"Faik Ouahab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouchra","family":"El Ghouti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumiya","family":"Chiheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madiha","family":"Eljazouly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Kaposi Sarcoma","author":"Bishop BN","year":"2026","unstructured":"Bishop BN, Lynch DT. Kaposi Sarcoma. StatPearls Publishing, Treasure Island, FL; 2026."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18061008","article-title":"Classic Kaposi sarcoma: current treatment strategies and emerging therapeutic approaches","volume":"18","author":"Revenko D","year":"2026","unstructured":"Revenko D, Shirron N, Shainer R, Avitan-Hersh E, Zer A. Classic Kaposi sarcoma: current treatment strategies and emerging therapeutic approaches. Cancers (Basel). 2026, 18:1008. 10.3390\/cancers18061008","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf024","article-title":"Fifth subtype of Kaposi sarcoma in HIV-negative MSM: a retrospective single-arm cohort study from a tertiary care center in NYC from 2000 to 2022","volume":"30","author":"Morales AE","year":"2025","unstructured":"Morales AE, Benson G, Glavan S, Giuliano R, Dickson MA. Fifth subtype of Kaposi sarcoma in HIV-negative MSM: a retrospective single-arm cohort study from a tertiary care center in NYC from 2000 to 2022. Oncologist. 2025, 30:10.1093\/oncolo\/oyaf024","journal-title":"Oncologist"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18091323","article-title":"Clinical implications of immune dysfunction in chronic lymphocytic leukemia","volume":"18","author":"Ju\u00e1rez-Salcedo LM","year":"2026","unstructured":"Ju\u00e1rez-Salcedo LM, Loscertales J. Clinical implications of immune dysfunction in chronic lymphocytic leukemia. Cancers (Basel). 2026, 18:10.3390\/cancers18091323","journal-title":"Cancers (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0060-9","article-title":"Kaposi sarcoma","volume":"5","author":"Cesarman E","year":"2019","unstructured":"Cesarman E, Damania B, Krown SE, Martin J, Bower M, Whitby D. Kaposi sarcoma. Nat Rev Dis Primers. 2019, 5:9. 10.1038\/s41572-019-0060-9","journal-title":"Nat Rev Dis Primers"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70084","article-title":"Monoclonal B\u2010cell lymphocytosis: the silent clone the haematologists should not neglect","volume":"43","author":"Serafin A","year":"2025","unstructured":"Serafin A, Sant'Antonio E, Mavilia F, Gandini F, De Pretis S, Scarf\u00f2 L, Ghia P. Monoclonal B\u2010cell lymphocytosis: the silent clone the haematologists should not neglect. Hematol Oncol. 2025, 43:e70084. 10.1002\/hon.70084","journal-title":"Hematol Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16213693","article-title":"Molecular mechanisms of Kaposi sarcoma-associated herpesvirus (HHV-8)-related lymphomagenesis","volume":"16","author":"Yu CJ","year":"2024","unstructured":"Yu CJ, Damania B. Molecular mechanisms of Kaposi sarcoma-associated herpesvirus (HHV-8)-related lymphomagenesis. Cancers (Basel). 2024, 16:3693. 10.3390\/cancers16213693","journal-title":"Cancers (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/JCAS.JCAS_127_19","article-title":"Far from luck\u2019s way: a concurrence of Kaposi sarcoma and cutaneous angiosarcoma in the setting of chronic lymphocytic leukemia","volume":"13","author":"Sezgin B","year":"2020","unstructured":"Sezgin B, Yigit YE, Tatar S, Selcukbiricik F, Durankus N, Kulac I, Atasoy P. Far from luck\u2019s way: a concurrence of Kaposi sarcoma and cutaneous angiosarcoma in the setting of chronic lymphocytic leukemia. J Cutan Aesthet Surg. 2020, 13:344-348. 10.4103\/JCAS.JCAS_127_19","journal-title":"J Cutan Aesthet Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00097-3","article-title":"PD-1 blockade with pembrolizumab in classic or endemic Kaposi\u2019s sarcoma: a multicentre, single-arm, phase 2 study","volume":"23","author":"Delyon J","year":"2022","unstructured":"Delyon J, Biard L, Renaud M, et al.. PD-1 blockade with pembrolizumab in classic or endemic Kaposi\u2019s sarcoma: a multicentre, single-arm, phase 2 study. Lancet Oncol. 2022, 23:491-500. 10.1016\/S1470-2045(22)00097-3","journal-title":"Lancet Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12051242","article-title":"Kaposi sarcoma, a trifecta of pathogenic mechanisms","volume":"12","author":"Rusu-Zota G","year":"2022","unstructured":"Rusu-Zota G, Manole OM, Gale\u0219 C, Porumb-Andrese E, Obad\u0103 O, Mocanu CV. Kaposi sarcoma, a trifecta of pathogenic mechanisms. Diagnostics (Basel). 2022, 12:1242. 10.3390\/diagnostics12051242","journal-title":"Diagnostics (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.54.5103","article-title":"Rituximab-containing chemotherapy (R-CHOP)-induced Kaposi\u2019s sarcoma in an HIV-negative patient with diffuse large B-cell lymphoma","volume":"54","author":"Ureshino H","year":"2015","unstructured":"Ureshino H, Ando T, Kojima K, et al.. Rituximab-containing chemotherapy (R-CHOP)-induced Kaposi\u2019s sarcoma in an HIV-negative patient with diffuse large B-cell lymphoma. Intern Med. 2015, 54:3205-3208. 10.2169\/internalmedicine.54.5103","journal-title":"Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13569-018-0097-7","article-title":"Reversible rituximab-induced rectal Kaposi's sarcoma misdiagnosed as ulcerative colitis in a patient with HIV-negative follicular lymphoma","volume":"8","author":"Billon E","year":"2018","unstructured":"Billon E, Stoppa AM, Mescam L, Bocci M, Monneur A, Perrot D, Bertucci F. Reversible rituximab-induced rectal Kaposi's sarcoma misdiagnosed as ulcerative colitis in a patient with HIV-negative follicular lymphoma. Clin Sarcoma Res. 2018, 8:11. 10.1186\/s13569-018-0097-7","journal-title":"Clin Sarcoma Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08517.x","article-title":"Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases","volume":"158","author":"Brambilla L","year":"2008","unstructured":"Brambilla L, Romanelli A, Bellinvia M, et al.. Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases. Br J Dermatol. 2008, 158:1339-1344. 10.1111\/j.1365-2133.2008.08517.x","journal-title":"Br J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1402a150","article-title":"Efficacy of long-pulsed Nd:YAG laser for classic Kaposi\u2019s sarcoma: a dermoscopic study","volume":"14","author":"Bostanci S","year":"2024","unstructured":"Bostanci S, Aygun Alizada M, Farabi B, Akay BN. Efficacy of long-pulsed Nd:YAG laser for classic Kaposi\u2019s sarcoma: a dermoscopic study. Dermatol Pract Concept. 2024, 14:e2024150. 10.5826\/dpc.1402a150","journal-title":"Dermatol Pract Concept"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.03.012","article-title":"Phase II single-arm study of nivolumab and ipilimumab (Nivo\/Ipi) in\u00a0previously treated classical Kaposi sarcoma (cKS)","volume":"33","author":"Zer A","year":"2022","unstructured":"Zer A, Icht O, Yosef L, et al.. Phase II single-arm study of nivolumab and ipilimumab (Nivo\/Ipi) in\u00a0previously treated classical Kaposi sarcoma (cKS). Ann Oncol. 2022, 33:720-727. 10.1016\/j.annonc.2022.03.012","journal-title":"Ann Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/491884-concurrent-kaposi-sarcoma-and-b-cell-lymphoma-in-an-hiv-negative-patient-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:24:13Z","timestamp":1785331453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/491884-concurrent-kaposi-sarcoma-and-b-cell-lymphoma-in-an-hiv-negative-patient-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.113592","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}